Table 1.
MYH mutations
Patients, n | Carcinomas, n | |
---|---|---|
Biallelics | 14 | 16 |
Y165C/Y165C | 2 | 3 |
G382D/G382D | 3 | 3 |
Y165C/G382D | 3 | 3 |
Y165C/891+3A>C | 1 | 1 |
Y165C/Y90X | 1 | 1 |
G382D/891+3A>C | 1 | 1 |
Y165C/Q377X | 1 | 2 |
1103delC/1103delC | 1 | 1 |
Y90X/1103delC | 1 | 1 |
Heterozygotes | 22 | 25 |
Y165C/− | 5 | 6 |
G382D/− | 17 | 19 |
Controls | 14 | 16 |